“WHO”的搜索结果，显示 841-850 项，共有 15482 项
... who have progressed after exhaustion of standard of care (SOC) or a SOC is ... who have no clinical evidence of residual (macroscopic) disease ...
... who receive SRS prior to surgery as compared to patients who receive surgery prior to SRS. A Study to Evaluate the Safety and Tolerability of HMPL-306 to ...
... who have Bacillus-Calmette-Guerin (BCG) unresponsive disease, with either carcinoma in situ with or without Ta/T1 disease. Establishment of Preclinical ...
WHO position paper on dengue vaccines. World Health Organization. https://www.who.int/news-room/questions-and-answers/item/dengue-vaccines. Accessed June 3 ...
... who have no clinical evidence of residual (macroscopic) disease following an attempt to perform definitive treatment (including surgery, radiation and/or ...
Vitamin D replacement may improve tumor response and survival and delay time to treatment in patients with cancer who are vitamin D insufficient. A Study to ...
Aims, purpose, or objectives: We will conduct a pilot trial to test whether caregivers of heart and lung transplant candidates who receive wellness coaching ...
Subjects who received at least one GM T cell infusion, will be asked to roll-over to this LTFU protocol upon either premature discontinuation from, or ...
... who specialize in kidney stone prevention. Mayo Clinic's Arizona campus has a multidisciplinary kidney stone clinic staffed by a nephrologist, a urologist ...
Subjects who received at least one GM T cell infusion, will be asked to roll ... The purpose of this study is to evaluate thymoma recurrence rates in patients who ...
妙佑医疗国际不为任何公司或产品背书。广告收入为我们的非营利使命提供支持。
浏览妙佑医疗国际出版社提供的畅销书以及书籍和简报的特别优惠。
您的捐赠可以抵税。请您慷慨解囊，和我们一起进行尖端研究和医护，共同推动医学的改变。